Since 1992 Medicare has reimbursed physicians on a fee-for-service basis. In 1997, as medical costs escalated, Congress began using a Sustainable Growth Rate (SGR) formula to reduce reimbursements if overall physician spending exceeded the growth in the economy.
Health Affairs
A new commentary by Gail Wilensky, released today as a web first by , reviews the recent history and future direction of physician payment reform. Since 1992 Medicare has reimbursed physicians on a fee-for-service basis. In 1997, as medical costs escalated, Congress began using a Sustainable Growth Rate (SGR) formula to reduce reimbursements if overall physician spending exceeded the growth in the economy.
However, in all but one year, Congress ignored its own earlier directive, postponing physician payment cuts even as costs remained out of control. With this game of “kick the can down the road” becoming increasingly tiresome to both lawmakers and physicians, Congress is now considering new legislation to do away with the current SGR formula and reimburse physicians for improving quality and lowering costs.
Health Affairs’
Wilensky is a Senior Fellow at Project HOPE, parent organization, who directed the Medicare and Medicaid programs under President George H Walker Bush. In her analysis, she observes that there seems to be growing agreement on the elements that a physician payment reform strategy should contain.
Read the full story here: http://bit.ly/1kGwG9p
Source: Health Affairs
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More